Monday, November 5, 2012

ALS MND News Digest

Neuralstem Swinging For The ALS Fences
Seeking Alpha
Lou Gehrig's Disease is the colloquial name for Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that inhibits proper messaging between the brain and muscles, eventually leading to complete paralysis in those who suffer from it.
See all stories on this topic »
Cytokinetics Announces Opening of BENEFIT-ALS, A Phase IIb Clinical Trial of ...
MarketWatch (press release)
BENEFIT-ALS is a Phase IIb, multi-national, double-blind, randomized, placebo-controlled, clinical trial designed to evaluate the safety, tolerability and potential efficacy of tirasemtiv (formerly CK-2017357) in patients with amyotrophic lateral ...
See all stories on this topic »

No comments:

Post a Comment